Abstract: The invention relates to methods for diagnosing or determining in a subject who underwent a solid organ transplantation the risk of developing graft rejection other than T cell mediated, comprising the steps of: measuring in a peripheral blood sample from said subject the RNA expression levels of a set of genes comprising at least CXCL10, FCGR1A, FCGR1B and TEMP1; determining from the measured expression levels of said set of genes, an expression profile; comparing the determined expression profile of said subject with a reference expression profile; and determining from said comparison, whether said subject is experiencing said rejection or has an increased risk of developing said rejection.

Abstract: The invention includes a prediction method for the screening or diagnosis or therapeutic management or prognosis of prostate cancer, including collecting individual input data and providing predictive information on the risk linked to a type of disease. The input data includes at least one variable or a combination of variables of the genetic type such as the identification of markers of genetic polymorphisms considered as being linked to the development of the disease. The invention also provides an individual prediction device for the screening or diagnosis or therapeutic management or prognosis of prostate cancer including first means for acquiring individual information data by a user, and at least a first software interface on which the said first means operate. The invention additionally includes a computer program product having the method and providing predictive information on risk linked to a disease.